Blood pressure control and diabetic retinopathy.

Item

http://www.wikidata.org/entity/Q43009620

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Blood pressure control and diabetic retinopathy.

@en

Blood pressure control and diabetic retinopathy.

@nl

type

Item

label

Blood pressure control and diabetic retinopathy.

@en

Blood pressure control and diabetic retinopathy.

@nl

prefLabel

Blood pressure control and diabetic retinopathy.

@en

Blood pressure control and diabetic retinopathy.

@nl

P1476

Blood pressure control and diabetic retinopathy.

@en

P2093

B E K Klein

http://www.w3.org/2001/XMLSchema#string

R Klein

http://www.w3.org/2001/XMLSchema#string

P2860

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Hypertension and diabetic retinopathy--what's the story?

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.

P304

365-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1136/BJO.86.4.365

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11450707

http://www.w3.org/2001/XMLSchema#string

P698

11914198

http://www.w3.org/2001/XMLSchema#string

P932

1771074

http://www.w3.org/2001/XMLSchema#string